Creative Biosciences has collected $88m in fresh funding, five years after being founded by a Sun Yat-Sen University professor.
Creative Biosciences, a China-based cancer screening system developer founded by Sun Yat-Sen University faculty, yesterday raised $88m in a series C round, according to DealStreetAsia.
Tsing Song Capital led the round, which also included GDD Industry Fund Investment Group, Oceanpine Capital, Judu Investment, Linden Asset, Sharewin Capital, Guangzhou Jinkong Fund, Think Real, IDG Capital and CDH Investments.
Founded in 2015, Creative Biosciences markets early-stage cancer screening and point-of-care diagnostic kits for conditions including colorectal, lung and liver cancer.…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
